Methods for treating familial adenomatous polyposis
AssigneeCancer Prevention Pharmaceuticals, Inc.
InventorsEugene Gerner, Alfred Cohen, Michelle Boytim
Life of this patent
Estimating the term…
Abstract
Provided are methods for preventing or delaying the need for surgical intervention in a patient having familial adenomatous polyposis (FAP) and an at least partially intact lower gastrointestinal tract. Also provided are methods for preventing or delaying the formation of neoplasia and/or cancer in a patient having FAP. The methods comprise administering an effective amount of a pharmaceutical therapy that comprises eflornithine and sulindac to a patient having FAP and an intact lower gastrointestinal tract.
Claims20
A method of treating a patient having familial adenomatous polyposis (FAP), the method comprising administering to the patient a pharmaceutical therapy comprising a combined effective amount of eflornithine and sulindac, wherein the patient has an at least partially intact lower gastrointestinal tract.
Dependencies are inferred from the claim text.